What types of cancer can be detected with cancer targeted gene panel test?

Cancer targeted gene panel tests are advanced diagnostic tools that can help identify specific genetic mutations associated with various types of cancer. In , these tests are available for many different types of cancer, including:

1. Breast cancer: Gene panel tests can be used to identify mutations in genes such as BRCA1 and BRCA2, which increase the risk of developing breast cancer.

2. Lung cancer: The test can detect mutations in genes such as EGFR, KRAS, and ALK, which can be used to guide treatment decisions.

3. Colon cancer: Gene panel tests can identify mutations in genes such as APC, which are associated with an increased risk of developing colon cancer.

4. Prostate cancer: These tests can detect mutations in genes such as BRCA1 and BRCA2, which increase the risk of developing prostate cancer.

5. Ovarian cancer: Gene panel tests can identify mutations in genes such as BRCA1 and BRCA2, which increase the risk of developing ovarian cancer.

6. Pancreatic cancer: These tests can detect mutations in genes such as KRAS, which are associated with an increased risk of developing pancreatic cancer.

Overall, cancer targeted gene panel tests can provide valuable insight into the genetic mutations that underlie specific types of cancer. By identifying these mutations, doctors can develop more effective and individualized treatment plans for their patients.

How accurate is cancer targeted gene panel test?

Cancer targeted gene panel tests are a type of genetic testing that can help identify genetic mutations associated with cancer. These tests are becoming increasingly popular in , as they are a non-invasive way to determine the genetic makeup of cancerous cells. But just how accurate are these tests in detecting cancer?

The accuracy of cancer targeted gene panel tests varies depending on several factors, including the specific genetic mutations being analyzed, the quality of the test, and the expertise of the laboratory performing the analysis. In general, these tests have been shown to have a high degree of accuracy, with some studies reporting a sensitivity of up to 95% in identifying the presence of certain cancer-associated mutations.

However, it's important to note that no test is perfect, and false positives can occur. This means that the test may identify a genetic mutation that is not actually present in the individual being tested. False negatives can also occur, when the test fails to detect a mutation that is actually present. It's important for individuals to work closely with their healthcare provider when interpreting the results of cancer targeted gene panel tests.

In , there are several reputable laboratories that offer cancer targeted gene panel testing, including Medanta-The Medicity, Fortis Memorial Research Institute, and Max Super Specialty Hospital. These laboratories have state-of-the-art equipment and highly trained staff who can provide accurate and reliable results.

In summary, cancer targeted gene panel tests can be a valuable tool in identifying genetic mutations associated with cancer. While the accuracy of the tests may vary depending on multiple factors, they have been shown to have a high degree of accuracy overall. Individuals in can take advantage of reputable laboratories in the area to obtain accurate and reliable results.

It's important to remember that cancer targeted gene panel tests are just one aspect of cancer diagnosis and treatment. These tests can provide valuable information, but they should be used in conjunction with other diagnostic tools and under the guidance of a healthcare professional. By working closely with their healthcare provider, individuals can obtain a better understanding of their cancer and develop a personalized treatment plan that takes into account their unique genetic makeup. Overall, cancer-targeted gene panel tests are a promising development in the field of cancer diagnosis and treatment, and they can offer hope to individuals who are facing a cancer diagnosis.

Are there any risks associated with cancer-targeted gene panel tests?

Cancer-targeted gene panel testing, also known as genetic sequencing, is a specialized test that examines specific genes in a person's DNA to identify any mutations or alterations that may increase their risk of developing certain types of cancer. While this test can provide valuable information about an individual's cancer risk, there are also some potential risks associated with it.

In , as in other parts of the world, the primary risk associated with cancer gene panel testing is the possibility of receiving false positive or false negative results. False positive results occur when the test indicates that a person has a cancer-causing mutation when they do not, while false negative results occur when the test fails to detect a mutation that is present. These errors can lead to unnecessary worry and anxiety in the case of a false positive result or a false sense of security in the case of a false negative result.

Another potential risk of cancer gene panel testing is the possibility of discovering a mutation that has no clear clinical significance. In some cases, a mutation may be identified that is not known to increase the risk of cancer or has not been studied enough to fully understand its implications. This can lead to confusion and uncertainty about how to interpret the results and make informed decisions about screening and preventive measures.

Additionally, some people may experience psychological distress as a result of receiving their test results, particularly if they learn that they have an increased risk of developing cancer. This can lead to anxiety, depression, and other mental health problems.

It is important to note that while these risks do exist, they are generally considered to be relatively low compared to the potential benefits of cancer gene panel testing. Additionally, advances in testing technology and interpretation methods are helping to reduce the risk of false positive and false negative results and to better understand the clinical significance of any identified mutations.

If you are considering cancer-targeted gene panel testing in , it is important to discuss the benefits and risks with your healthcare provider. They can help you understand the testing process, the potential outcomes, and how the results may impact your health and well-being. By working together, you can make an informed decision about whether cancer gene panel testing is right for you, and take steps to manage any potential risks or concerns.

What is the cost of cancer targeted gene panel test?

Cancer targeted gene panel test is a diagnostic test that helps in identifying specific genetic mutations in cancer cells. The cost of this test may vary depending on the hospital or diagnostic center in . However, the average cost of cancer targeted gene panel tests in is Rs. 22,000.

Several factors can affect the cost of this test, such as the number of genes being tested, the clinical expertise of the testing laboratory, and the availability of advanced technologies. Generally, a targeted gene panel test includes testing for a range of genes that are commonly associated with various types of cancers.

It's essential to note that some hospitals or diagnostic centers may offer cancer-targeted gene panel tests at a discounted rate or through government-sponsored programs. Therefore, it's always advisable to check with the hospital or diagnostic center for the latest pricing information.

In conclusion, cancer-targeted gene panel test is an advanced diagnostic tool that can help in the early detection and personalized treatment of cancer. The cost of this test in may vary, and it's always beneficial to compare the pricing before undergoing the test.

The Benefits of Using Cancer-Targeted Gene Panel Lung

What are the specific genes tested in a cancer-targeted gene panel for lung cancer?

A cancer-targeted gene panel for lung cancer is a test that looks at specific genes in the tumor sample. The specific genes examined in this type of test can vary depending on the type of cancer and the laboratory performing the test. Common genes that are part of a cancer-targeted gene panel for lung cancer include EGFR, ALK, ROS1, BRAF, RET, MET, and KRAS. These genes all play a role in cell growth, differentiation, and survival, and alterations in them can cause cancer to develop. Additionally, these genes can help to identify which treatments may be most effective for a particular type of cancer.

What kind of technology is used in a cancer-targeted gene panel for lung cancer?

A cancer-targeted gene panel test in for lung cancer uses a variety of technologies to identify and detect mutations in cancer-associated genes. These technologies include targeted sequencing, targeted deep sequencing, targeted hybridization, and targeted gene panels. Targeted sequencing uses sequencing technology to look for single nucleotide variants and short indels. Targeted deep sequencing is used to detect larger structural variations, such as rearrangements. Targeted hybridization (also called targeted array-based technology) is used to detect deletions, duplications, and mutations in specific genes. Targeted gene panels are used to look at a panel of genes that are known to be associated with lung cancer and other cancers. The specific genes that may be included in a panel will vary depending on the type of cancer and the individual in question.

What is the cost of a cancer-targeted gene panel for lung cancer?

The cost of a cancer-targeted gene panel test near me for lung cancer can vary. It depends on the number of genes included in the panel and the type of technology used to test for them. Generally, the cost of a gene panel for a lung cancer test price is ₹22,000. It is important to discuss the cost of the panel with your doctor or genetic counselor prior to having the test.

Components – ALK, ROS1, MET amplification, KRAS, BRAF, ERBB2, EGFR
Clinical Utility – for therapeutic indication of lung cancer in patients.
Methodology – fluorescence in situ hybridization (FISH) and next-generation sequencing (NGS)
Turn-Around Time – sample should reach by Saturday, and reports will be ready within 18 days
Patient Preparation –

Before undergoing a targeted gene panel test for lung cancer, it is essential to follow some patient preparation steps. These steps may vary depending on the specific instructions provided by the healthcare provider or laboratory conducting the test. However, some general recommendations for patient preparation for targeted gene panel lung tests include:

1. Consult with your healthcare provider: Talk to your healthcare provider about any medications you are taking or any health conditions you have that may affect the test results or the procedure itself. It is important to provide a complete medical history to your healthcare provider.

2. Fasting: Some targeted gene panel lung tests require fasting for a certain period before the test. It is important to follow the fasting instructions provided by your healthcare provider or laboratory.

3. Blood thinners: If you are taking any blood-thinning medications, such as aspirin or warfarin, you may need to stop taking them for a period before the test. Your healthcare provider will advise you on when to stop and resume taking these medications.

4. Clothing: Wear comfortable and loose-fitting clothing to the test to make it easier for the healthcare provider to access the necessary veins for blood collection.

5. Hydration: It is essential to drink enough water before the test to keep the veins hydrated, which will make it easier for the healthcare provider to draw blood.

6. Follow specific instructions: Your healthcare provider or laboratory may provide specific instructions related to the test that you need to follow. It is important to follow these instructions carefully.

7. Mental preparation: It is normal to feel anxious or nervous before any medical procedure. Talking to your healthcare provider or a counselor can help you mentally prepare for the test.

Remember to ask any questions you have about the procedure and the test results to your healthcare provider or laboratory.

Collect – Tumor tissue
Specimen Preparation – formalin fixed paraffin embedded tissue block. Protect the slides from excessive heat
Storage/Transport Temperature – room temperature (18-25 degrees C)
Stability – Ambient: Indefinitely; refrigerated: indefinitely
Unacceptable Conditions – alternate fixatives and decalcified specimens
MRP – 22000.00
Special Instructions – clinical history is mandatory including surgical pathology reports